| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TEREX CORP | Director | Common Stock, par value $.01 | 32,058 | $1,842,053 | $57.46 | 04 Nov 2022 | Direct |
| Lexeo Therapeutics, Inc. | Director | Common Stock | 30,627 | $214,086 | $6.99 | 25 Nov 2024 | Direct |
| Lexeo Therapeutics, Inc. | Director | Stock Option (right to buy) | 25,000 | 26 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | 26 Jun 2025 | 1 | $0 | 4 | Director | 30 Jun 2025, 17:00 |
| LXEO | Lexeo Therapeutics, Inc. | 25 Nov 2024 | 1 | +$104,852 | 4 | Director | 26 Nov 2024, 17:00 |
| LXEO | Lexeo Therapeutics, Inc. | 25 Jun 2024 | 1 | $0 | 4 | Director | 27 Jun 2024, 17:01 |
| LXEO | Lexeo Therapeutics, Inc. | 02 Nov 2023 | 0 | $0 | 3 | Director | 02 Nov 2023, 21:17 |
| TEX | TEREX CORP | 04 Nov 2022 | 1 | -$824,400 | 4 | Director | 08 Nov 2022, 12:54 |